[Case finding in bronchial carcinoma: cost-effectiveness].
The data in the study sponsored by the National Cancer Institute make it possible to calculate the cost of early detection of bronchial carcinoma by radiologic and/or cytologic examination. For the initial series of tests (prevalence study), the cost of one case of screening-related survival amounts to: 417 chest roentgenograms + 417 sputum cytological examinations + 33 investigations to clarify abnormal chest roentgenograms. If cytological investigation alone is performed 2500 examinations are needed for one case of screening-related survival. If these examinations are repeated on a yearly basis, the benefit related to this screening effort is less than 1 case of survival/1000 subjects/year.
D000368:Aged; D003362:Cost-Benefit Analysis; D003954:Diagnostic Services / Q000191:economics; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000453:epidemiology*; D008297:Male; D008400:Mass Chest X-Ray / Q000191:economics*; D008875:Middle Aged; D013183:Sputum / Q000166:cytology*; D014481:United States
Dépistage du carcinome bronchique: rapport coût-efficacité.